COMS

An international audience of researchers and clinicians from the fields of diabetes, endocrinology and metabolism, diabetes technology developers as well as general & family medicine practitioners will attend and presentations will be given by renowned professionals.

1) Cancer - Magnetic Nanotherapy, Receptor based Targeting
2) Nanostructured Materials for Regenerative Medicine - Dentistry, Cardiovascular Science, Neurology, Orthopedics
3) Diagnostics & Therapy - Molecular Imaging, Nano-Sensing, Drug Delivery
4) Multidisciplinary Nano-Technologies - NanoBio-Photonics, NanoBio-Electronics, Nano-Toxicology
Special Session I: How to bridge the gap between engineers,clinical scientists and doctors
Special Session II: Commercialisation of NanoMedicine Products / Processes

Up to 26 AMA PRA Category 1 Credits.

Up to 17 AMA PRA Category 1 Credits.

The chairs have set up a blog to provide information about the speakers scheduled for the 2012 Biology of Acute Respiratory Infection GRC.

The Conference will bring together an array of investigators who are at the forefront of their fields within craniofacial biology. It will provide unique opportunities for junior investigators and graduate students to present their work in poster format and interact with leaders in the field. In addition, a group of poster presenters will be selected to give brief oral presentations. The collegial and interdisciplinary atmosphere of this Conference, with formal discussion sessions as well as opportunities for informal gatherings in the afternoons and evenings, will provide an excellent venue for investigators from different disciplines in craniofacial biology to brainstorm and to develop collaborations across fields.

This symposium will be of interest to analytical, pharmaceutical and regulatory scientists involved in pharmaceutical research, development and manufacturing. It will be of particular interest to scientists and managers engaged in analytical development or quality control, where advances in analytical technologies and practices can enhance productivity, problem-solving or quality-by-design capabilities.

Up to 12.5 AMA PRA Category 1 Credits.

A sensitive reduction of its incidence has been obtained compared to a couple of decades ago but a very likely increase is about to occur due to the increased survivability of babies at lowest gestational ages, who are also the babies with highest risk of developing GMH-IVH.

The meeting pits together the best researchers available in this field to discuss the different aspects of the topic: pathogenesis, ultrasound and magnetic resonance appearance, treatment of the post-haemorrhagic hydrocephalus and its impact on later neurological outcome.

Furthermore, it will present possible breakthroughs in the treatment of this disease, based on studies on new experimental animal models and clinical studies on very premature neonates.

HDL Satellite meetings are an established feature of the triennial ISA meetings and regularly attract many of the leading researchers in the field.

The objective of this HDL satellite symposium is to provide a forum for presentation and discussion of state-of-the-art knowledge of the biology and biochemistry of high-density lipoprotein (HDL) and of recent developments in therapeutics directed to modifications of HDL metabolism and function. The program will reflect the many recent exciting developments in this field and will include invited presentations by many leading researchers in the field. Additional oral presentations will be selected from submitted abstracts and poster sessions will also form an integral part of the scientific program.

Our key note speaker, Professor Peter Passmore, Professor of Ageing and Geriatric Medicine at Queen’s University Belfast, and a leading international researcher in Alzheimer’s Disease and Vascular Dementia, will update us on the interface between vascular risk factors, Mild Cognitive Impairment and Dementia.

Experts from NSW and interstate will speak on Dementia prevention, early symptoms and diagnosis, current and emerging treatments, through to managing advanced disease.

With the prevalence of Dementia rising each year, our conference aims to foster impeccable Dementia care and management for the future.

Now in its sixth year, the world’s largest embolization meeting — Global Emoblization Symposium and Technologies (GEST) — is the first and only gathering that features an in-depth, evidence-based review of the full range of possibilities.

As the leading resource on embolization, GEST brings together renowned experts to present a one-of-a-kind program that focuses on the latest findings, the newest techniques and the most important issues. GEST covers all aspects of embolization through lectures, panel discussions, debates, live demonstrations and hands-on sessions.

NADPH oxidases of the NOX family have in recent years been shown to comprise the predominant source of reactive oxygen species (ROS) produced by most types of cells. It is abundantly clear that the science in this field is moving very rapidly, with many exciting advances in understanding of the basic biochemistry and cell biology of the NOX family of enzymes, particularly the contrasting properties and functional roles of the seven discrete isoforms comprising the family. Moreover, NOX-generated ROS are directly involved in a wide range of both physiologic and pathologic processes. Many linkages between NOX enzymes and disease pathogenesis are being elucidated and this knowledge is dramatically accelerating advances in the identification of new and often unexpected therapeutic targets and development of disease-modifying pharmacologic agents. The NOX Gordon Conference program has been clearly established as the top forum for the presentation and discussion of the latest advances in this field. Thus, the 2012 NOX GRC/GRS meetings promise to be timely, exciting, and paradigm-challenging.

The program for the meeting has been developed around the theme of "NOX Biology and its Translation to Human Disease and Therapy." The preliminary conference program comprises nine scientific sessions, four with basic themes and five with a disease-oriented translational emphasis, including one session devoted entirely to recent exciting advances in the development and testing of small-molecule NOX inhibitors. Each session features a discussion leader and three to four speakers, plus a few young investigator presentations to be selected from among an anticipated ~100 poster abstracts. There will be ample time for vigorous discussion after each talk. The GRS program will feature speakers selected from among trainee abstracts, as well as career development components and mentoring by senior scientists. Attracting a diverse group of participants is a major priority, as reflected for example in the high prevalence of women scientists (35%) listed in the preliminary GRC program.

This conference will bring together leading scientists and clinicians in the Fragile X and ASD fields. Topics will include molecular genetics, model system characterizations, synaptic signaling and function studies, small molecule trials and clinical reports.

The aim of the meeting is to bring together scientists from a variety of disciplines in order to define the current state of this dynamic field and to discuss and set future research agendas. This GRC conference offers the unique opportunity for junior investigators and graduate students to get together and exchange ideas with leaders in the field in a friendly and relaxed atmosphere at the Salve Regina University Campus, Newport. Some submitted abstracts will be selected for short talks. Students and post-docs are strongly encouraged to apply. We are making a special effort to obtain funds to provide individuals from endemic countries with travel awards.

This Gordon Research Conference is the world's largest forum for fostering interactions among IF and other interested researchers. The Conference provides an unprecedented opportunity to learn about the latest cutting edge developments in the functions of IF. This GRC has always fostered a free exchange of ideas, tools and reagents, and has facilitated the establishment of many productive interdisciplinary collaborations. The attendance of young scientists is strongly encouraged. In support of this the GRC Board of Trustees has provided resources to inaugurate the first IF Gordon Research Seminar which will precede the Conference and will be organized by graduate students and postdoctoral fellows. All applicants are invited to present posters describing their latest research and a number of platform presentations will be chosen from the submitted abstracts in order to ensure inclusion of the latest breakthroughs during the formal sessions. Significant time for discussion will be scheduled into the sessions to promote the lively exchange of ideas and to consider alternate interpretations of data presented. The schedule will also allow ample free time in the afternoons and after the last evening session to foster the informal interactions that have been the hallmark of the IF Gordon Conferences.